Marksans Pharma Limited (NSE:MARKSANS)

Marksans Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 12, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	78,366	100,815	68,836	31,903	18,627	20,445
Market Cap Growth	64.42%	46.46%	115.77%	71.27%	-8.89%	259.35%
Enterprise Value	74,750	96,315	63,549	29,746	16,052	19,467
Last Close Price	172.93	221.69	151.06	69.62	44.78	48.99
PE Ratio	22.34	26.49	21.94	11.98	9.97	8.57
Forward PE	17.90	5.39	5.39	5.39	5.39	5.39
PS Ratio	2.95	3.84	3.16	1.72	1.25	1.49
PB Ratio	3.15	4.05	3.30	1.81	1.52	2.26
P/TBV Ratio	3.33	4.28	3.51	1.95	1.67	2.50
P/FCF Ratio	-	298.76	319.14	17.36	35.20	15.47
P/OCF Ratio	-	48.78	29.88	13.44	18.77	11.45
PEG Ratio	-	0.80	0.80	0.80	0.80	0.80
EV/Sales Ratio	2.82	3.67	2.92	1.61	1.08	1.42
EV/EBITDA Ratio	14.98	19.21	14.65	9.29	6.68	5.81
EV/EBIT Ratio	18.04	21.63	16.54	10.34	7.50	6.30
EV/FCF Ratio	-	285.42	294.63	16.19	30.33	14.73
Debt / Equity Ratio	0.13	0.13	0.12	0.07	0.09	0.04
Debt / EBITDA Ratio	0.65	0.61	0.53	0.36	0.43	0.12
Debt / FCF Ratio	-	9.54	11.32	0.67	2.09	0.30
Asset Turnover	-	0.89	0.89	0.97	1.04	1.29
Inventory Turnover	-	1.64	1.95	2.07	1.76	1.87
Quick Ratio	-	2.64	2.99	3.34	2.09	1.62
Current Ratio	-	4.62	4.78	4.91	3.37	3.02
Return on Equity (ROE)	-	16.73%	16.35%	17.76%	17.55%	30.69%
Return on Assets (ROA)	-	9.40%	9.86%	9.39%	9.33%	18.13%
Return on Capital (ROIC)	10.07%	10.82%	11.39%	11.16%	11.75%	23.74%
Return on Capital Employed (ROCE)	-	16.10%	16.80%	15.60%	16.70%	33.30%
Earnings Yield	4.47%	3.77%	4.56%	8.35%	10.03%	11.67%
FCF Yield	-	0.34%	0.31%	5.76%	2.84%	6.46%
Dividend Yield	0.46%	0.36%	0.40%	0.72%	0.56%	0.51%
Payout Ratio	-	7.14%	7.22%	3.82%	5.67%	1.72%
Buyback Yield / Dilution	0.27%	-	-9.09%	-1.49%	-	0.00%
Total Shareholder Return	0.73%	0.36%	-8.69%	-0.77%	0.56%	0.51%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.